Thomas Fremming Dejgaard
15PUBLICATIONS
50CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Dec 29, 2025
Glucose-dependent insulinotropic polypeptide reduces postprandial glucose excursions but does not protect from hypoglycaemia in persons with type 1 diabetes-A randomised placebo-controlled study.Bjørn Hoe, Sebastian M N Heimbürger, Lærke S Gasbjerg
|Oct 16, 2025
Efficacy and safety of oral semaglutide treatment in a Danish type 2 diabetes outpatient clinic: Real-world evidence.Alexandra A Weinreich, Jonatan I Bagger, Jeanette T Jørgensen
|Oct 06, 2025
Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes: Design and rationale of the REC1TE trial.David S Mathiesen, Josefine V Hansen, Aske Høck
|Jul 29, 2025
The Steno 1 study: Multifactorial intervention to reduce cardiovascular disease in type 1 diabetes-rationale and protocol of the prospective, randomized, open-labelled multicentre study.Elisabeth B Stougaard, Mads R Andersen, Jonatan I Bagger
|Aug 28, 2024
Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): A randomized, double-blind, placebo-controlled trial.Thomas F Dejgaard, Christian S Frandsen, Urd Kielgast
Pageof 3
Frequent Collaborators
6 joint publications
Jens Juul Holst
6 joint publications
Filip Krag Knop
3 joint publications
Sten Madsbad
3 joint publications
Bolette Hartmann
3 joint publications
Tina Vilsbøll
2 joint publications
Signe Schmidt
2 joint publications
Nicklas J Johansen
2 joint publications
Mikkel B Christensen
2 joint publications
Natasha Chidekel Bergman
2 joint publications
Sebastian Møller Nguyen Heimbürger
